Aura Biosciences

MA - Boston

Biotechnology1 H-1B visas (FY2023)

Website LinkedIn Careers Page

Focus: Delivery by Pseudo-Viruses

Aura Biosciences is a life sciences company focused on Delivery by Pseudo-Viruses.

OncologyNephrology

Open Jobs

Pipeline & Clinical Trials

Standard of Care

Choroidal Melanoma

N/A

Clinical Trials (1)

NCT05266430Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

N/A

Breast Ultrasound Imaging With Investigational AI Software

Breast Cancer

N/A

Clinical Trials (1)

NCT07427407Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

N/A

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Choroidal Melanoma

N/A

Clinical Trials (1)

NCT03941379A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

N/A

Individual interviews

Aging

N/A

Clinical Trials (1)

NCT05982145The Use of Compression in Institutions and at People's Homes

N/A

Intradialytic exercise on stationary bicycles

End Stage Renal Disease on Hemodialysis

N/A

Clinical Trials (1)

NCT02860312Long Term Physical Activity for Hemodialysis Patients

N/A

Training program

Overweight

N/A

Clinical Trials (1)

NCT03940924HIIT + RT on Body Composition and Gut Microbiota in Postmenopausal Women (PACWOMan)

N/A

Proteolysis

Hemodialysis Patients

N/A

Questionnaire

Aging

N/A

Clinical Trials (1)

NCT04993573Acceptability, Representations and Experiences of the COVID-19 Pandemic

N/A

Focus groups

Aging

N/A

Clinical Trials (1)

NCT04763811Acceptability Study of Sensor in Elderly People's House Living Alone (Fragility Box)

N/A

Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product R

Mood

N/A

Clinical Trials (1)

NCT06664944Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

N/A

Immune Response Following COVID-19 in Hemodialysis Patients

Dialysis; Complications

N/A

Clinical Trials (1)

NCT05307601Immune Response Following COVID-19 in Hemodialysis Patients

N/A

Individual interviews

Disease

N/A

Clinical Trials (1)

NCT04774263The Acceptability of a Real-time Localization for Patients and Caregivers

N/A

Non-interventional, digital, patient-reported, real-world study

Choroidal Melanoma

N/A

Clinical Trials (1)

NCT07421739Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

N/A

hemodialysis

Chronical Kidney Disease

N/A

Clinical Trials (1)

NCT03350308Prediction of Risk of Hypotension in Hemodialysis

N/A

Semi-structured interviews

Aged, 80 and Over

N/A

Clinical Trials (1)

NCT05872490Predictors Associated With Maintaining Driving in Old Age

N/A

Observational

Choroidal Melanoma

N/A

Clinical Trials (1)

NCT07338968A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

N/A

AU-011

Non-muscle-invasive Bladder Cancer

Phase 1

Clinical Trials (1)

NCT05483868A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Phase 1

Light-activated AU-011

Uveal Melanoma

Phase 1/2

Clinical Trials (1)

NCT03052127Study in Subjects With Small Primary Choroidal Melanoma

Phase 1/2

Preoperative SRS

Brain Metastases

Phase 2

Clinical Trials (1)

NCT04503772Preoperative Stereotactic Radiosurgery for Brain Metastases

Phase 2

AU-011

Eye Cancer

Phase 2

Clinical Trials (1)

NCT06643884Suprachoroidal Administration in Subjects With Metastases to the Choroid

Phase 2

AU-011

Uveal Melanoma

Phase 2

Clinical Trials (1)

NCT04417530Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Phase 2

Bel-sar

Choroidal Melanoma

Phase 3

Clinical Trials (1)

NCT06007690A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Phase 3